Who owns GlaxoSmithKline?

Key details on GlaxoSmithKline (Ticker: GSK)

Who owns GlaxoSmithKline?

Is GSK a good stock to own? Find out who bought GlaxoSmithKline, who sold GlaxoSmithKline (GSK) stock, and who holds a large position in GlaxoSmithKline.

Fund Name Number of Shares Share Valuation As Of
Dodge & Cox 60.23M $3.22B June 30, 2014
Gruss & Co 25.33M $547.95M Sept. 30, 2012
Royal Bank of Canada 14.11M $754.73M June 30, 2014
Fisher Investments 11.49M $528.13M Sept. 30, 2014
STATE STREET CORPORATION 10.81M $578.12M June 30, 2014
Bank of America Corporation 10.76M $575.56M June 30, 2014
PRIMECAP Management Company 9.18M $490.37M March 31, 2014
T. Rowe Price Associates 9.04M $483.45M June 30, 2014
Renaissance Technologies 8.87M $474.34M June 30, 2014
Wells Fargo & Company 8.52M $455.79M June 30, 2014
Allianz Asset Management AG 7.24M $387.09M June 30, 2014
FMR 6.59M $352.27M March 31, 2014
FIDUCIARY MANAGEMENT INC /WI/ 6.01M $321.32M March 31, 2014
Inves 5.90M $315.11M Dec. 31, 2013

Who sold GlaxoSmithKline?

Fund Name Date Sold Number of Shares Sold Share Valuation
Tradewinds Global Investors Sept. 30, 2011 6.16M $253.40M
Johnson Investment Counsel June 30, 2011 19.93M $947.34M
Allianz Global Investors of America June 30, 2011 10.17M $435.88M
Brandes Investment Partners June 30, 2010 5.95M $202.44M